Tag: policy_change

The federal rescheduling of medical cannabis from Schedule I to Schedule III is the most consequential shift in U.S. controlled substance policy in over fifty years. For those building the infrastructure for legal psilocybin medicine, it is also the clearest map yet of where this field is headed. The banking barriers, insurance gaps, and tax…